Citation Impact
Citing Papers
Preoperative CTLA-4 Blockade: Tolerability and Immune Monitoring in the Setting of a Presurgical Clinical Trial
2010 StandoutNobel
Prognostic Factors of Disease-Free Survival after Thyroidectomy in 170 Young Patients with a RET Germline Mutation: A Multicenter Study of the Groupe Français d'Etude des Tumeurs Endocrines
2010
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
2011
Prognostic Significance of Somatic RET Oncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study
2007
Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma
2013
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Apoptosis induction by combination of drugs or a conjugated molecule associating non-steroidal anti-inflammatory and nitric oxide donor effects in medullary thyroid cancer models: implication of the tumor suppressor p73
2015
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
2005 StandoutNobel
Changing trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinoma
2015
Genotype-phenotype correlation in multiple endocrine neoplasia type 2
2012
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Prediction of lateral lymph node metastases in medullary thyroid cancer
2008
Current approaches to medullary thyroid carcinoma, sporadic and familial
2006
Hereditary hyperparathyroidism—a consensus report of the European Society of Endocrine Surgeons (ESES)
2015
The Diagnostic Value of Calcitonin Measurement in Wash-out Fluid from Fine-Needle Aspiration of Thyroid Nodules in the Diagnosis of Medullary Thyroid Cancer
2013
Prognostic Impact of Serum Calcitonin and Carcinoembryonic Antigen Doubling-Times in Patients with Medullary Thyroid Carcinoma
2005
Kalzitoninbestimmung zur Frühdiagnose des medullären Schilddrüsenkarzinoms
2010
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors
2010
Heterophilic antibodies causing falsely high serum calcitonin values
2006
Dynamic risk stratification for medullary thyroid cancer according to the response to initial therapy
2016
Peak Incidence of Pheochromocytoma and Primary Hyperparathyroidism in Multiple Endocrine Neoplasia 2: Need for Age-Adjusted Biochemical Screening
2013
Thyroid cancer
2016 Standout
The Clinical Presentation (Symptoms and Signs) of Sporadic and Familial Chromaffin Cell Tumours (Phaeochromocytomas and Paragangliomas)
2003
High Frequency of Bone/Bone Marrow Involvement in Advanced Medullary Thyroid Cancer
2005
Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times
2008
Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin
2010
Identification of occult metastases of medullary thyroid carcinoma by pentagastrin‐stimulated intravenous calcitonin sampling followed by targeted surgery
2007
A comprehensive map of molecular drug targets
2016 Standout
Low parathyroid hormone levels after thyroid surgery: A feasible predictor of hypocalcemia
2002
Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocality
2003 Standout
Pheochromocytomas in von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical Phenotypes
2001
Impact of Routine Measurement of Serum Calcitonin on the Diagnosis and Outcome of Medullary Thyroid Cancer: Experience in 10,864 Patients with Nodular Thyroid Disorders
2004
Biological Relevance of Medullary Thyroid Microcarcinoma
2012
Descending control of pain
2002 Standout
Altered pulsatile gonadotropin signaling in nutritional deficiency in the male
1995
High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients
2013
Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients
2004
The Thyroid Nodule
2004 Standout
Réintervention pour carcinome médullaire de la thyroïde : résultats à long terme
2001
Is routine supplementation therapy (calcium and vitamin D) useful after total thyroidectomy?
2002
Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes
2009
Phaeochromocytoma
2005 Standout
The Genetic Basis of Pheochromocytoma
2003
Head and neck cancer
2008 Standout
Thyroid nodules: a review of current guidelines, practices, and prospects
2008
Hypercalcitoninemia is not Pathognomonic of Medullary Thyroid Carcinoma
2009
Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer
2007 Standout
Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study
2006
Radioisotope-guided surgery in patients with pheochromocytoma and recurrent medullary thyroid carcinoma
2001
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations
2008
2012 European Thyroid Association Guidelines for Genetic Testing and Its Clinical Consequences in Medullary Thyroid Cancer
2012
Long‐term prognosis of medullary thyroid carcinoma
2008
Failure to Recognize Multiple Endocrine Neoplasia 2B: More Common Than We Think?
2007
Presentation of a kindred with familial medullary thyroid carcinoma and Cys611Phe mutation of the RET proto-oncogene demonstrating low grade malignancy
2001
Benefit-Risk Balance of Reoperation for Persistent Medullary Thyroid Cancer
2012
Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update
2013
A duplication of 12 bp in the critical cysteine rich domain of the RET proto-oncogene results in a distinct phenotype of multiple endocrine neoplasia type 2A
1997
Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto‐oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal
2006
Micromedullary Thyroid Cancer: How Micro Is Truly Micro?
2009
Prospects of Remission in Medullary Thyroid Carcinoma According to Basal Calcitonin Level
2005
Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls
2008
Embolization of Hepatic and Adrenal Metastasis to Treat Cushing’s Syndrome Associated with Medullary Thyroid Carcinoma: A Case Report
2007
MEDULLARY THYROID CARCINOMA: A 20‐YEAR EXPERIENCE FROM A CENTRE IN SOUTH INDIA
2007
Thyroid Imaging Reporting and Data System for US Features of Nodules: A Step in Establishing Better Stratification of Cancer Risk
2011 Standout
Normal Range of Calcitonin in Children Measured by a Chemiluminescent Two-Site Immunometric Assay
2006
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
LONG‐TERM TREATMENT OF METASTATIC MEDULLARY THYROID CARCINOMA WITH THE SOMATOSTATIN ANALOGUE OCTREOTIDE
1990
Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas
2011
Estimated Risk of Pheochromocytoma Recurrence After Adrenal-Sparing Surgery in Patients With Multiple Endocrine Neoplasia Type 2A
2006
Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma
2011
External Beam Radiation Therapy for Thyroid Cancer
2008
The Timing of Total Thyroidectomy in RET Gene Mutation Carriers Could Be Personalized and Safely Planned on the Basis of Serum Calcitonin: 18 Years Experience at One Single Center
2011
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels
2000
Thyroid Nodules: Clinical Importance, Assessment, and Treatment
2007
Anti‐carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma
1997
Simultaneous Medullary and Papillary Thyroid Cancer: A Novel Entity?
2011
Evolution of Surgical Treatment of Primary Hyperparathyroidism in Patients With Multiple Endocrine Neoplasia Type 2A
2010
von Hippel-Lindau disease
2003 Standout
Preoperative diagnosis of medullary thyroid carcinoma: Fine needle aspiration cytology as compared with serum calcitonin measurement
2005
TheRETProto-Oncogene in Multiple Endocrine Neoplasia Type 2 and Hirschsprung's Disease
1996
Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine
1994
Das medulläre Schilddrüsenkarzinom
2015
Advances in the management of hereditary medullary thyroid cancer
2004
Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome
2001
Somatostatin receptor imaging in persistent medullary thyroid carcinoma
1995
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Duplication of 9 base pairs in the critical cysteine-rich domain of the RET proto-oncogene causes multiple endocrine neoplasia type 2A
1998
Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking
2007
Treatment of pancreatic cancer
1997
Prognostic Variables and Calcitonin in Medullary Thyroid Cancer
2005
Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer
2007
When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?
2003
Novel germline mutation in the transmembrane region of RET gene close to Cys634Ser mutation associated with MEN 2A syndrome
2004
Mutations of theRET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease
1997
Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study
2001
Treatment of medullary thyroid carcinoma: an update.
2001
Postoperative calcitonin study in medullary thyroid carcinoma.
2004
Parathyroid surgery in familial hyperparathyroid disorders*
2004
Rationale for Central and Bilateral Lymph Node Dissection in Sporadic and Hereditary Medullary Thyroid Cancer
2003
Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation
2008
A Novel Point Mutation of theRETProtooncogene Involving the Second Intracellular Tyrosine Kinase Domain in a Family with Medullary Thyroid Carcinoma
2004
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
2006 Standout
Selective Activation of Somatostatin Receptor Subtypes Differentially Modulates Secretion and Viability in Human Medullary Thyroid Carcinoma Primary Cultures: Potential Clinical Perspectives
2006
The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT
2009
Cellular localization and possible functions for brain histamine: Recent progress
1988
Contralateral cervical and mediastinal lymph node metastasis in medullary thyroid cancer: Systemic disease?
2005
Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights
2015
Adjuvant external beam radiation for medullary thyroid carcinoma
2010
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
Pheochromocytoma: The Expanding Genetic Differential Diagnosis
2003
False serum calcitonin high levels using a non-competitive two-site IRMA
2001
Extent of Surgery Affects Survival for Papillary Thyroid Cancer
2007 Standout
Total Thyroidectomy Plus Neck Dissection in Differentiated Papillary Thyroid Carcinoma Patients
2007 Standout
Management of medullary thyroid carcinoma and MEN2 syndromes in childhood
2011
Pediatric Ethics Guidelines for Hereditary Medullary Thyroid Cancer
2011
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Hereditary medullary thyroid cancer in Slovenia – genotype-phenotype correlations
2006
Interactions between growth hormone-releasing hormone and glucocorticoids in male rats
1989
The von Hippel–Lindau protein, HIF hydroxylation, and oxygen sensing
2005 StandoutNobel
Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients
2003
Consensus on management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI)
2015
Reversibility of ′Secondary Hypercalcitoninemia′ After Kidney Transplantation
2005
Medullary thyroid carcinoma
2004
Pheochromocytoma: Update on Diagnosis, Localization, and Management
1995
Determinants of life expectancy in medullary thyroid cancer: age does not matter
2006
Basal Calcitonin Levels and the Response to Pentagastrin Stimulation in Patients After Kidney Transplantation or on Chronic Hemodialysis as Indicators of Medullary Carcinoma
1999
Treatment of advanced medullary thyroid carcinoma with a combination of recombinant interferon α-2b and octreotide
1996
Multiple endocrine neoplasia type 2 andRET: from neoplasia to neurogenesis
2000
A census of human cancer genes
2004 Standout
Advances in the follow-up of differentiated or medullary thyroid cancer
2012
Very early detection of RET proto‐oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children
2002
Medullary thyroid carcinoma
2000
Management of advanced medullary thyroid cancer
2015
The value of plasma markers for the clinical behaviour of phaeochromocytomas
2002
Role of leptin in the neuroendocrine response to fasting
1996 StandoutNature
Prophylactic thyroidectomy in multiple endocrine neoplasia: the impact of molecular mechanisms of RET proto-oncogene
2003
Age at Diagnosis of Pheochromocytoma Differs According to Catecholamine Phenotype and Tumor Location
2010
Prognosis of medullary thyroid carcinoma
2006
Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia
2006
A Five-Year Report on Experience in the Detection of Pheochromocytoma
2000
Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B
2009
Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging
2003
Medullary thyroid microcarcinoma
2011
Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin
2013
Familial Medullary Thyroid Carcinoma with Noncysteine RET Mutations: Phenotype-Genotype Relationship in a Large Series of Patients
2001
Procalcitonin levels predict clinical course and progression‐free survival in patients with medullary thyroid cancer
2009
Tumours of familial origin in the head and neck
2006
Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre
2006
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma
2012
Multiple Endocrine Neoplasia Type 2
2003
The Use of Preoperative Routine Measurement of Basal Serum Thyrocalcitonin in Candidates for Thyroidectomy due to Nodular Thyroid Disorders: Results from 2733 Consecutive Patients
2010
Unilateral Subtotal Adrenalectomy for Pheochromocytoma in Multiple Endocrine Neoplasia Type 2 Patients
2011
Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism
2011
Early Onset of Medullary Thyroid Carcinoma in a Kindred with Multiple Endocrine Neoplasia Type IIA Associated with Cutaneous Lichen Amyloidosis
2002
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Prevalence and Clinical Spectrum of Nonsecretory Medullary Thyroid Carcinoma in a Series of 839 Patients with Sporadic Medullary Thyroid Carcinoma
2012
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Normal Perioperative Serum Calcitonin Levels in Patients with Advanced Medullary Thyroid Carcinoma: Case Report and Review of the Literature
2008
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Ectopic Adrenocorticotropic Hormone-Syndrome in Medullary Carcinoma of the Thyroid: A Retrospective Analysis and Review of the Literature
2005
Measurement of Calcitonin and Calcitonin Gene–Related Peptide mRNA Refines the Management of Patients with Medullary Thyroid Cancer and May Replace Calcitonin-Stimulation Tests
2012
Inherited Medullary Thyroid Cancer and the Duty to Warn: Revisiting Pate v. Threlkel in Light of HIPAA
2005
A Rare Extracellular D631Y Germl ine Mutation of the RET Proto-Oncogene in Two Korean Families with Multiple Endocrine Neoplasia 2A
2006
Multiple Endocrine Neoplasia Type 2B with a RET Proto-Oncogene A883F Mutation Displays a More Indolent Form of Medullary Thyroid Carcinoma Compared with a RET M918T Mutation
2010
Clinical Value of 18-Fluorine-Fluorodihydroxyphenylalanine Positron Emission Tomography/Computed Tomography in the Follow-Up of Medullary Thyroid Carcinoma
2010
Routine Measurement of Serum Calcitonin is Useful for Early Detection of Medullary Thyroid Carcinoma in Patients with Nodular Thyroid Diseases
2001
Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma
2015
Frequency and Relevance of Elevated Calcitonin Levels in Patients with Neoplastic and Nonneoplastic Thyroid Disease and in Healthy Subjects
2004
Effect of the Antihistaminic Agents Meclastine and Dexchlorpheniramine on the Response of Human Growth Hormone to Arginine Infusion and Insulin Hypoglycemia
1976
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study
2013
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin‐stimulation test?
2012
RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors
2006
Potent Interaction Between Glucocorticoids and Growth Hormone-Releasing Factor in Vivo
1983 Science
Management of Simple Nodular Goiter: Current Status and Future Perspectives
2003
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
American Association Of Clinical Endocrinologists, Associazione Medici Endocrinologi, And European Thyroid Association Medical Guidelines For Clinical Practice For The Diagnosis And Management Of Thyroid Nodules
2010 Standout
Prospective Trial of Unilateral Surgery for Nonhereditary Medullary Thyroid Carcinoma in Patients without Germline RET Mutations
2002
Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases
2002 Standout
In vivo somatostatin receptor imaging in medullary thyroid carcinoma.
1993
Comparison of Two Provocative Tests for Calcitonin in Medullary Thyroid Carcinoma: Omeprazole vs Pentagastrin
2002
Effects of Food Deprivation on the Feedback Regulation of the Hypothalamic-Pituitary-Thyroid Axis of the Rat*
1985
Medullary Thyroid Carcinoma: Comparison With Papillary Thyroid Carcinoma and Application of Current Sonographic Criteria
2010
Genotype‐Phenotype Based Surgical Concept of Hereditary Medullary Thyroid Carcinoma
2007
Pheochromocytoma in an 8‐year‐old patient with multiple endocrine neoplasia type 2A: Implications for screening
2013
von Hippel-Lindau Disease
2006 StandoutNobel
Familial Medullary Thyroid Carcinoma: Clinical Variability and Low Aggressiveness Associated withRETMutation at Codon 804
2002
Predictive Value of Serum Calcitonin Levels for Preoperative Diagnosis of Medullary Thyroid Carcinoma in a Cohort of 5817 Consecutive Patients with Thyroid Nodules
2006
Thyroid Microcarcinoma: Fine-Needle Aspiration Diagnosis and Histologic Follow-up
2002
Growth Hormone Secretion by Cultured Rat Anterior Pituitary Cells. Effects of Culture Conditions and Dexamethasone*
1983
Risk and Penetrance of Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A Families with Mutations at Codon 634 of the RET Proto-Oncogene
1998
Clinical and Genetic Experience in Turkish Multiple Endocrine Neoplasia Type 2 Families
2007
Improved Diagnostic Methods in the Follow-Up of Medullary Thyroid Carcinoma by Highly Specific Calcitonin Measurements*
2000
Potency and Tolerance of Calcitonin Stimulation with High-Dose CalciumVersusPentagastrin in Normal Adults
2009
Reciprocal variations in insulin-stimulated glucose uptake and pancreatic insulin secretion in women with normal glucose tolerance
1995
Incidentally Discovered Medullary Thyroid Cancer: Diagnostic Strategies and Treatment
2011
Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients
2006
Pheochromocytoma in MEN 2A Syndrome. Study of 54 Patients
2008
Estimation of Risk of Inherited Medullary Thyroid Carcinoma in Apparent Sporadic Patients
2001
Procalcitonin: A Marker for the Diagnosis and Follow-Up of Patients with Medullary Thyroid Carcinoma
2008
Role of prophylactic thyroidectomy in RET 790 familial medullary thyroid carcinoma
2011
Latent Subclinical Medullary Thyroid Carcinoma: Diagnosis and Treatment
1998
Review of Multiple Endocrine Neoplasia Type 2A in Children: Therapeutic Results of Early Thyroidectomy and Prognostic Value of Codon Analysis
2003
Tumor Recurrence and Hypertension Persistence After Successful Pheochromocytoma Operation
1997
A Phase II Trial of Imatinib Therapy for Metastatic Medullary Thyroid Carcinoma
2007
Calcitonin Measurement in the Evaluation of Thyroid Nodules in the United States: A Cost-Effectiveness and Decision Analysis
2008
Multiple Endocrine Neoplasia Type 2A in a Kindred With C634Y Mutation
2005
Cancer treatment and survivorship statistics, 2019
2019 Standout
The Role of Radiation Therapy in the Treatment of Medullary Thyroid Cancer
2010
Comparison of Calcium and Pentagastrin Tests for the Diagnosis and Follow-Up of Medullary Thyroid Cancer
2011
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
The Management of Post-Thyroidectomy Hypocalcemia
1996
Continuing Controversies in the Management of Thyroid Nodules
2005
Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma
1997
Biomarker-Based Risk Stratification for Previously Untreated Medullary Thyroid Cancer
2010
Thyroid Nodules: Rational Management
2000
Adrenal-sparing surgery for phaeochromocytoma
1999
Leptin Prevents Fasting-Induced Suppression of Prothyrotropin-Releasing Hormone Messenger Ribonucleic Acid in Neurons of the Hypothalamic Paraventricular Nucleus*
1997
Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma.
1996
Increased Risk of Lymph Node Metastasis in Multifocal Hereditary and Sporadic Medullary Thyroid Cancer
2007
Guidelines for the management of thyroid cancer
2014 Standout
Latin American Thyroid Society recommendations for the management of thyroid nodules
2009
Current Update on Medullary Thyroid Carcinoma
2013
RET Proto-Oncogene in the Development of Human Cancer
1999
Determinative Factors of Biochemical Cure after Primary and Reoperative Surgery for Sporadic Medullary Thyroid Carcinoma
1998
Long‐term Outcome of Reoperations for Medullary Thyroid Carcinoma
2008
MANAGEMENT OF HEREDITARY PHEOCHROMOCYTOMA IN VON HIPPEL-LINDAU KINDREDS WITH PARTIAL ADRENALECTOMY
1999
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
Tumortyp- und tumorstadienorientiertes chirurgisches Konzept bei Karzinomen der Schilddrüse
2010
Procalcitonin and the Calcitonin Gene Family of Peptides in Inflammation, Infection, and Sepsis: A Journey from Calcitonin Back to Its Precursors
2004
Medullary thyroid carcinoma in Hong Kong Chinese patients.
2005
Reciprocal Variations in Insulin-Stimulated Glucose Uptake and Pancreatic Insulin Secretion in Women With Normal Glucose Tolerance
1995
Thyroid carcinoma
2003 Standout
Evidence‐based Approach to the Management of Sporadic Medullary Thyroid Carcinoma
2007
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of E Modigliani being referenced
[Medullary cancer of the thyroid gland in France in 1995].
1996
Detection of a germline mutation at codon 918 of the RET proto-oncogene in French MEN 2B families
1995
Preoperative Calcitonin Levels Are Predictive of Tumor Size and Postoperative Calcitonin Normalization in Medullary Thyroid Carcinoma
2000
Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC)
1999
Pheochromocytoma in multiple endocrine neoplasia type 2: European study
1995
Effect of a Somatostatin Analog (SMS 201-995) in Perfusion on Basal and Pentagastrin-Stimulated Calcitonin Levels in Medullary Thyroid Carcinoma
1988
Pentagastrin Testing in Patients with Renal Insufficiency: Normal Responsivity of Mature Calcitonin
1998
Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 cases
1993
Sporadic Medullary Microcarcinoma of the Thyroid: A Retrospective Analysis of Eighty Cases
1998
Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma
2001
Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients
1998
Influence of starvation on hormonal control of hypophyseal secretion in rats
1988
Interest of Routine Measurement of Serum Calcitonin: Study in a Large Series of Thyroidectomized Patients
1997
Effects of Short-Term Subcutaneous Administration of SMS 201-995 on Calcitonin Plasma Levels in Patients Suffering from Medullary Thyroid Carcinoma
1989
Risk and Penetrance of Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A Families with Mutations at Codon 634 of theRETProto-Oncogene1
1998
Diagnosis and treatment of medullary thyroid cancer
2000
Multiple Endocrine Neoplasia Type 2: Management of Patients and Subjects at Risk
1997
Calcitonin Precursor Levels in Human Medullary Thyroid Carcinoma
2003
[Effects of subcutaneous administration of sandostatine (SMS 201.995) in 18 cases of thyroid medullary cancer].
1989
[Type 2 endocrine neoplasms. Clinical aspects].
1998
Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families.
1997
Growth Hormone Response to Arginine in Normal and Hyperthyroid Females Under Propanolol
1969
PARTIAL SOMATOTROPHIN INSUFFICIENCY IN CUSHING'S SYNDROME
1969
Lymphocytic hypophysitis. A review of 145 cases.
1999
[Early therapeutic management of patients genetically predisposed to medullary thyroid cancer].
1998
Effets du glucose et de l'arginine sur la s�cr�tion d'insuline au cours des syndromes de Cushing
1970
Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type IIa: Retrospective French Multicentric Study
1996
Transient Hypocalcemia after Thyroidectomy
1993
EFFECTS OF CIMETIDINE ON THYROID HORMONES
1982
Effect of a Short-Term Oral Administration of Cimetidine and Ranitidine on the Basal and Thyrotropin-Releasing Hormone-Stimulated Serum Concentrations of Prolactin, Thyrotropin and Thyroid Hormones in Healthy Volunteers
1986
Somatostatin receptors and somatostatin content in medullary thyroid carcinomas.
1991
Evidence of a Thyrotropin-Releasing Hormone-Dependent Increase in Plasma Thyrotropin during Refeeding of Starved Rats*
1983